{"filing":{"accession_number":"0001703057-26-000031","cik":"0001703057","ticker":"ABCL","company_name":"AbCellera Biologics Inc.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"abcl-20260601.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305726000031/abcl-20260601.htm"},"events":[{"id":6659,"run_id":5829,"accession_number":"0001703057-26-000031","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The filing discloses the appointment of Victor Sandor as a new director to the Board of AbCellera Biologics Inc. effective June 1, 2026. The Board has determined Dr. Sandor is independent under NASDAQ rules. Director appointments are material events affecting the composition and governance of the company and would be relevant to a reasonable investor's assessment of the registrant.","company_name":"AbCellera Biologics Inc.","ticker":"ABCL","filing_date":"2026-06-05","form":"8-K","submitted_at":null,"items":[{"id":4702,"accession_number":"0001703057-26-000031","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Victor Sandor as a new director to the Board of AbCellera Biologics Inc. effective June 1, 2026. The Board has determined Dr. Sandor is independent under NASDAQ rules. Director appointments are material events affecting the composition and governance of the company and would be relevant to a reasonable investor's assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T16:52:23.661043+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4702,"accession_number":"0001703057-26-000031","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Victor Sandor as a new director to the Board of AbCellera Biologics Inc. effective June 1, 2026. The Board has determined Dr. Sandor is independent under NASDAQ rules. Director appointments are material events affecting the composition and governance of the company and would be relevant to a reasonable investor's assessment of the registrant.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T16:52:23.661043+00:00","company_name":"AbCellera Biologics Inc.","ticker":"ABCL","filing_date":"2026-06-05"}]}